The impact of patient advocacy: the case of innovative breast cancer drug reimbursement.
Nahuis
Roel
R
Department of Innovation Studies, Utrecht University, Utrecht, The Netherlands. nahuis@zonnet.nl
Boon
Wouter P C
WP
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics; D004059:Diffusion of Innovation; D005260:Female; D006291:Health Policy; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000706:statistics & numerical data*; D017008:Negotiating; D009426:Netherlands; D010344:Patient Advocacy; D011057:Politics
D000970:Antineoplastic Agents